List of Excipients in API viloxazine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing viloxazine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Supernus Pharmaceuticals Inc | QELBREE | viloxazine hydrochloride | 17772-131 | ALCOHOL | 2033-02-07 |
| Supernus Pharmaceuticals Inc | QELBREE | viloxazine hydrochloride | 17772-131 | AMMONIA | 2033-02-07 |
| Supernus Pharmaceuticals Inc | QELBREE | viloxazine hydrochloride | 17772-131 | BUTYL ALCOHOL | 2033-02-07 |
| Supernus Pharmaceuticals Inc | QELBREE | viloxazine hydrochloride | 17772-131 | D&C YELLOW NO. 10 | 2033-02-07 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for viloxazine hydrochloride
Excipient focus: ALCOHOL
viloxazine hydrochloride drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
viloxazine hydrochloride drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
viloxazine hydrochloride drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
viloxazine hydrochloride drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
viloxazine hydrochloride drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
viloxazine hydrochloride drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
viloxazine hydrochloride drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
viloxazine hydrochloride drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
viloxazine hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
viloxazine hydrochloride drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
viloxazine hydrochloride drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
viloxazine hydrochloride drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: OLEIC ACID
viloxazine hydrochloride drug variants containing OLEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing OLEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
viloxazine hydrochloride drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
viloxazine hydrochloride drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
viloxazine hydrochloride drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
viloxazine hydrochloride drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
viloxazine hydrochloride drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
viloxazine hydrochloride drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
viloxazine hydrochloride drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
viloxazine hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
viloxazine hydrochloride drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
viloxazine hydrochloride drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | viloxazine hydrochloride | 17772-131 |
| >Company | >Ingredient | >NDC |
viloxazine hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
